Summarizing 2024: A Year of Growth, Milestones, and Impact
We have stepped into 2025 with renewed energy and ambitious goals, ready for the new year. At the same time we want to take a moment and look back at 2024. Many team members say that the highlight of 2024 was the customer event we arranged in June. We are already planning the event for summer 2025, so stay tuned for that.
2024 Highlights: Growth in Action
Numbers often tell the best stories, so here are some standout achievements from the past year:
- We achieved significant growth: Our revenue experienced a significant upswing, more than tripling over the past year
- Production Milestone: Our customers produced an incredible 26,000 fully quality-controlled tablets using our technology.
- Global Reach: With 58 business trips spanning 11 countries, we brought our solutions closer to those who need them.
- Top Regions: Switzerland, Estonia, Germany, and France led the way as key adopters of our technology.
- Advancing Development: Our software team wrote an impressive 179,000 lines of code, powering new solutions and features.
- Expanding Insights: We added 172 new customer reports, including critical stability and dissolution data for new APIs.
Major Milestones Achieved
Beyond the numbers, 2024 was marked by these significant achievements:
- Winning Key Tenders: We secured major contracts, with prominent customers choosing CurifyLabs as their trusted partner.
- Technology Validation: Germany’s Zentrallabor, a leading lab specializing in compounded drug quality, validated our technology with exceptional results.
- Entering New Markets: We expanded into new markets such as Sweden and Italy, further growing our global presence.
- Regulatory Excellence: Our software team met the rigorous demands of GMP Annex 11, including flawless results in a cybersecurity test.
- Portfolio Growth: New APIs, including hormones and pain management formulations, were added to our expanding library, giving customers more options.
- Team Strength: We welcomed senior leaders, including Pasi Heiskanen as COO and Hannes Jantunen as Lead Hardware Engineer, to support our next phase of growth.
Looking Ahead: Scaling Success in 2025
The focus for 2025 is clear: scaling our commercial operations. We aim to bring our innovative solutions to more markets and deepen partnerships with those who share our vision of transforming personalized medicine.
Media Spotlight
2024 also brought significant media coverage, particularly in Sweden, with features in:
- LäkemedelsVärlden: “3D-läkemedel snart verklighet i Sverige”
- Läkartidningen: “3D-Printed Medications to Fill Gaps in Swedish Market”
These stories highlighted our partnership with APL and our work in using 3D-printing technology to help patients in need.
Impact at the Core
At CurifyLabs, our mission is to make a real difference where it matters most. Stories of children battling cancer and benefiting from our technology remind us why we do what we do. These moments inspire us to keep pushing boundaries and innovating for a better future.
Thank You
We’re grateful to our partners, customers, and dedicated team for your trust and support. Together, we’re creating solutions that truly matter.
2025—bring it on!
Warm regards,
Charlotta & Niklas
Team CurifyLabs
